<narrative xml:lang="en">Support the national Malaria, TB, and HIV programs in scaling up interventions, treatment and care services nationwide, among the most affected populations - Djibouti (01-Jan-2021-31-Dec-2023)</narrative>

47045-DJI-Z-UNDP-1

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative xml:lang="en">Support the national Malaria, TB, and HIV programs in scaling up interventions, treatment and care services nationwide, among the most affected populations - Djibouti (01-Jan-2021-31-Dec-2023)</narrative> Djibouti, Multicomponent, United Nations Development Programme (UNDP Djibouti)This program has the following goals: Réduire de moitié les nouvelles infections par le VIH d'ici à 2022 / Reduce new HIV infections by half by 2022.. Allonger l'espérance de vie et la qualité de vie des personnes infectés et affectés par le VIH et les agents de co-morbidité / Increase the life expectancy and quality of life of people infected and affected by HIV and co-morbidities.. Mettre fin à la tuberculose » à l’horizon 2030 / End Tuberculosis by 2030.. Contribuer à l’amélioration de l’état de santé de la population de la République de Djibouti par la réduction du fardeau humain et socio-économique dus au paludisme / To contribute to the improvement of the population of the Republic of Djibouti state of health by reducing the human and socio-economic burden due to malaria.. The objectives of this program are: Au moins 90% des PVVIH connaissent leur statut sérologique d’ici à 2022 / At least 90% of PLHIV know their HIV status by 2022.. Le taux de survie à 12, 24 et 36 mois est de respectivement de 95%, 93% et 90%, d’ici 2022 / Retention rates at 12, 24 and 36 months are 95%, 93% and 90%, respectively, by 2022.. Identifier au moins 9.000 cas de tuberculose sensible et au moins 300 TB-MR d’ici à fin 2024 / Identify at least 9,000 cases of drug-susceptible TB and at least 300 MDR-TB by the end of 2024.. Guérir au moins 90% des tuberculoses prouvées bactériologiquement et plus de 75% des tuberculoses résistantes à la rifampicine d’ici 2024 / Cure at least 90% of bacteriologically proven tuberculosis and more than 75% of rifampicin-resistant tuberculosis by 2024.. Prévention de la tuberculose / Prevent tuberculosis.. Renforcer les capacités managériales et d’intervention de l’unité centrale du programme / Strengthen the managerial and intervention capacities of the programme's central unit.. Réduire la mortalité due au paludisme dans les formations sanitaires d’ici fin 2024 / Reduce malaria mortality in health facilities by the end of 2024.. Réduire la morbidité liée au paludisme de 50% d’ici 2024, par rapport aux données de 2019 en vue d’atteindre zéro cas autochtone d’ici fin 2030 / Reduce malaria morbidity by 50% by 2024, compared to 2019 data, with the aim of reaching zero indigenous cases by the end of 2030.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

United Nations Development Programme

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS Tuberculosis and Malaria Communications

Web Team

+41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division

Marie, JN BAPTISTE

Fund Portfolio Manager

+41 58 791 1700 marie.jnbaptiste@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS Tuberculosis and Malaria Communications

Web Team

+41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

Djibouti

HIV Malaria Multicomponent RSSH Tuberculosis

HIV -> Differentiated HIV Testing Services -> Facility-based testing

HIV -> PMTCT -> Prong 3: Preventing vertical HIV transmission

HIV -> PMTCT -> Prong 4: Treatment, care and support to mothers living with HIV, their children and families

HIV -> Prevention -> Behavior change interventions

HIV -> Prevention -> Gender-based violence prevention and post violence care

HIV -> Prevention -> Prevention and management of co-infections and co-morbidities (Prevention)

HIV -> Treatment, care and support -> Differentiated ART service delivery and HIV care

HIV -> Treatment, care and support -> Prevention and management of co-infections and co-morbidities (Treatment, care and support)

HIV -> Treatment, care and support -> Treatment monitoring - Viral load

Malaria -> Case management -> Facility-based treatment

Malaria -> Case management -> Other case management intervention(s)

Malaria -> Case management -> Private sector case management

Malaria -> Case management -> Therapeutic efficacy surveillance

Malaria -> Vector control -> Entomological monitoring

Malaria -> Vector control -> IEC/BCC (Vector control)

Malaria -> Vector control -> Indoor residual spraying (IRS)

Malaria -> Vector control -> Long-lasting insecticidal nets (LLIN) - Continuous distribution - Community-based

Malaria -> Vector control -> Long-lasting insecticidal nets (LLIN) - Mass campaign - Universal

Malaria -> Vector control -> Other vector control measures

Multicomponent -> COVID-19 -> Case management, clinical operations and therapeutics

Multicomponent -> COVID-19 -> Country-level coordination and planning

Multicomponent -> COVID-19 -> COVID diagnostics and testing

Multicomponent -> COVID-19 -> COVID-19 control and containment including health systems strengthening

Multicomponent -> COVID-19 -> COVID-19 CSS: Community-based organizations institutional capacity building

Multicomponent -> COVID-19 -> COVID-19 CSS: Community-led advocacy and research

Multicomponent -> COVID-19 -> COVID-19 CSS: Community-led monitoring

Multicomponent -> COVID-19 -> COVID-19 CSS: Social mobilization

Multicomponent -> COVID-19 -> Gender-based violence prevention and post violence care (COVID-19)

Multicomponent -> COVID-19 -> Health products and waste management systems

Multicomponent -> COVID-19 -> Infection prevention and control, and protection of the health workforce

Multicomponent -> COVID-19 -> Laboratory systems

Multicomponent -> COVID-19 -> Mitigation for HIV programs

Multicomponent -> COVID-19 -> Mitigation for Malaria programs

Multicomponent -> COVID-19 -> Mitigation for TB programs

Multicomponent -> COVID-19 -> Respond to human rights and gender related barriers to services

Multicomponent -> COVID-19 -> Risk communication

Multicomponent -> COVID-19 -> Risk mitigation for disease programs

Multicomponent -> COVID-19 -> Surveillance systems

Multicomponent -> COVID-19 -> Surveillance: Epidemiological investigation and contact tracing

Multicomponent -> Program management -> Coordination and management of national disease control programs

Multicomponent -> Program management -> Grant management

RSSH -> RSSH: Community systems strengthening -> Community-based monitoring

RSSH -> RSSH: Community systems strengthening -> Community-led research and advocacy

RSSH -> RSSH: Community systems strengthening -> Institutional capacity building, planning and leadership development

RSSH -> RSSH: Health management information systems and M&E -> Program and data quality

RSSH -> RSSH: Health products management systems -> Policy, strategy, governance

RSSH -> RSSH: Health products management systems -> Procurement capacity

RSSH -> RSSH: Health products management systems -> Regulatory/quality assurance support

RSSH -> RSSH: Health products management systems -> Storage and distribution capacity

RSSH -> RSSH: Health sector governance and planning -> Policy and planning for national disease control programs

RSSH -> RSSH: Human resources for health, including community health workers -> In-service training (excluding community health workers)

RSSH -> RSSH: Integrated service delivery and quality improvement -> Quality of care

RSSH -> RSSH: Integrated service delivery and quality improvement -> Service organization and facility management

RSSH -> RSSH: Laboratory systems -> Information systems and integrated specimen transport networks

RSSH -> RSSH: Laboratory systems -> National laboratory governance and management structures

RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting

RSSH -> RSSH: Monitoring and evaluation systems -> Surveys

Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB)

Tuberculosis -> MDR-TB -> Treatment (MDR-TB)

Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention)

Tuberculosis -> TB care and prevention -> Collaborative activities with other programs and sectors (TB care and prevention)

Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention)

Tuberculosis -> TB care and prevention -> Key Populations (TB care and prevention) - Children

Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Prisoners

Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention)

Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions

Tuberculosis -> TB/HIV -> TB/HIV - Prevention

7565850.55

2633505.67

3579825.40

-13230.08 Global Fund Commitment to DJI-Z-UNDPP01.

Global Fund to Fight AIDS, Tuberculosis and Malaria